Asianet Newsable on MSN
COVID-19 vaccines generated up to $809 per dollar spent: Why rich countries benefited more
A study found COVID-19 vaccines generated returns of up to $809 for every dollar invested during their first year of rollout.
Helen Branswell covered issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. In April 2020, people around the globe were struggling to ...
Canada becomes the first country to authorize both Moderna’s mRNA seasonal influenza vaccine, mFLUSIVA ®, and combination influenza and COVID-19 vaccine, mCOFLU ® CAMBRIDGE, M ...
This year, the agency predicts that COVID-19, the flu and RSV could cause a similar number of cases and hospitalizations. ...
Our World in Data also publishes data on COVID-19 fatality rates, in which low-income countries also experience worse ...
SIRVA was rare after COVID-19 and flu shots, but COVID-19 vaccination had about 7 more cases per 100,000 doses in a study of 1.8 million.
From Stratus to Cicada, several variants are on the radar as COVID-19 activity rises, impacting how the virus spreads, its severity, and how it interacts with the immune system. As we near ...
Alberta doesn't have a shortage of COVID-19 vaccine, despite pharmacists' concerns, according to Primary and Preventative ...
Judge Aidee Hernandez talks to 3NEWS about the Covid-19 fraud case, Social Services, and the County's purpose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results